Nicotine-induced inflammatory decreasing effect on passive skin Arthus reaction in paraventricular nucleus-lesioned wistar rats

Pharmacology and Toxicology

Volumn 92, Issue 3, 2003, Pages 125-130

  Kubo, Kaoru ^a   Kita, Taizo ^a   Narushima, Itaru ^a   Tanaka, Takeshi ^a   Nakatani, Toshiaki ^a   Nakashima, Toshikatsu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CORTICOSTERONE; CYCLOHEXIMIDE; GLUCOCORTICOID RECEPTOR ANTAGONIST; HEXAMETHONIUM; MECAMYLAMINE; MIFEPRISTONE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTHUS PHENOMENON; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG ANTAGONISM; EXTRAVASATION; IMMUNOSTIMULATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN SENSITIZATION; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ARTHUS REACTION; CORTICOSTERONE; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEXAMETHONIUM; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MALE; MECAMYLAMINE; MIFEPRISTONE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RABBITS; RATS; RATS, WISTAR; SKIN; TIME FACTORS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0037354867     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920304.x     Document Type: Article

References (30)

1. Andersson, K., R. Siegel, K. Fuxe & P. Eneroth: Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin and prolactin secretion. Acta Physiol. Scand. 1983, 118, 35-40.
2. Cam, G. R., J. R. Bassett & K. D. Cairncross: The action of nicotine on the pituitary-adrenal cortical axis. Arch. Int. Pharmacodyn. 1979, 237, 49-66.
3. Carnuccio, R., M. DiRosa, B. Guerrasio, T. Iuvone & L. Sautebin: Vasocortin: a novel glucocorticoid-induced anti-inflammatory protein. Brit. J. Pharmacal. 1987, 90, 443-445.
4. Davies, B. D., W. Hoss, J.-P. Lin & F. Lionetti: Evidence for a noncholinergic nicotine receptor on human phagocytic leukocytes. Mol. Cell. Biochem. 1982, 44, 23-31.
5. Fujieda, K & T. Hiroshige: Changes in rat hypothalamic content of corticotropin- releasing factor (CRF) activity, plasma ACTH and corticosterone under stress and the effect of cycloheximide. Acta Endocrinol. 1978, 89, 10-19.
6. Harada, M., M. Takeuchi, T. Fukao & K. Katagiri: A simple method for the quantitative extraction of dye extravasated into the skin. J. Pharm. Pharmacol. 1971, 23, 218-219.
7. Hoss, W., J.-P. Lin, S. Matchett & B.D. Davies: Characterization of noncholinergic nicotine receptors on human granulocytes. Biochem. Pharmacol. 1986, 35, 2367-2372.
8. Jay, M., S. Kojima & M. N. Gillespie: Nicotine potentiates superoxide anion generation by human neutrophils. Toxicol. Appl. Pharmacol. 1986, 86, 484-487.
9. Kawano, H., S. Daikoku & T. Shibasaki: CRF-containing neuron systems in the rat hypothalamus: retrograde tracing and immunohistochemical studies. J. Comp. Neurol. 1988, 272, 260-268.
10. Kuriyama, K., A. Fujiwara, K. Inagaki & Y. Abe: Anti-inflammatory action of a novel peptide, SEK-1005, isolated from a Streptomyces. Eur. J. Pharmacol. 2000, 390, 223-228.
11. Lee, E. H., H. C. Hung, K. T. Lu, W. H. Chen & H. Y. Chen: Protein synthesis in the hippocampus associated with memory facilitation by corticotropin-releasing factor in rat. Peptides 1992, 13, 927-937.
12. Matta, S. G., H. S. Beyer, K. M. McAllen & B.M. Sharp: Nicotine elevates rat plasma ACTH by a central mechanism. J. Pharmacol. Exp. Therap. 1987, 243, 217-226.
13. Matta, S. G. & B. M. Sharp: The role of the fourth cerebroventricle in nicotine-stimulated prolactin release in the rat: involvement of catecholamine. J. Pharmacol. Exp. Therap. 1992, 260, 1285-1291.
14. Matta, S. G., Y. Fu, J. D. Valentine & B. M. Sharp: Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 1998, 23, 103-113.
15. Miao, F. J.-P., N. L. Benowitz, A. I. Basbaum & J. D. Levine: Sympathoadrenal contribution to nicotine and muscarinic modulation of bradykinin-induced plasma extravasation in the knee joint of the rat. J. Pharmacol. Exp. Therap. 1992, 262, 889-895.
16. Miao, F. J.-P., N. L. Benowitz, P.H. Heller & J. D. Levine: Contribution of adrenal hormones to nicotine-induced inhibition of synovial plasma extravasation in the rat. Brit. J. Pharmacol. 1997, 120, 298-304
17. Nowak, D., U. Ruta & G. Piasecka: Nicotine increase human polymorphonuclear leukocytes chemotactic response-a possible additional mechanism of lung injury in cigarette smokers. Exp. Pathol. 1990, 39, 37-43.
18. Okuda, H., S. Shioda, Y. Nakai, H. Nakayama, M. Okamoto & T. Nakashima: Immunocytochemical localization of nicotinic acetylcholine receptor in rat hypothalamus. Brain Res. 1993, 625, 145-151.
19. Owens, M. J. D. L. Kinght, J. C. Ritchie & C. B. Nemeroff: The 5-hydroxytryptamine 2 agonist, (±)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. J. Pharmacol. Exp. Therap. 1990, 256, 787-794.
20. Oyanagi, Y. & S. Suzuki: Vasoregulin: a glucocorticoid-inducible vascular permeability inhibitory protein. Agents Actions 1985, 17, 270-277.
21. Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, New York 1986.
22. Peeters, B. W., C. M. van Rijn, J. M. Vossen & A. M. Coenen: Involvement of glucocorticoids in the acquired immobility response is dependent on the water temperature. Physiol. Behav. 1992, 51, 127-129.
23. Salminen, O., T. Seppa, H. Gaddnas & L. Ahtee: Effect of acute nicotine on Fos protein expression in rat brain during chronic nicotine and its withdrawal. Pharmacol. Biochem. Behav. 2000, 66, 87-93.
24. Schafer, M., S. A. Mousa & C. Stein: Corticotropin-releasing factor in antinociception and inflammation. Eur. J. Pharmacol. 1997, 323, 1-10.
25. Sharp, B. M. & S. G. Matta: Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. Endocrinology 1993, 133, 11-19.
26. Shimizu, K., S. Amagaya & Y. Ogihara: Analysis of corticosterone in the serum of mice and rats using high-performance liquid chromatography. J. Chromatogr. 1983, 272, 170-175.
27. Totti, N., K. T. McCusker, E. J. Campbell, G. I. Griffen & R. M. Senior: Nicotine is chemotactic for neutrophils and enhances neutrophils responsiveness chemotactic peptides. Science 1984, 223, 169-171.
28. Valentine, J. D., S. G. Matta & B. M. Sharp: Nicotine-induced cFos expression in the hypothalamic paraventricular nucleus is dependent on brainstem effect: correlations with cFos in catecholaminergic and noncatecholaminergic neurons in the nucleus tractus solitarius. Endocrinology 1996, 137, 622-630.
29. Weidenfeld, J., M. Bodoff, D. Saphier & T. Brenner: Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 1989, 50, 132-138.
30. Yong, T., M. Q. Zheng & D. S. Linthicum: Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse. J. Neuroimmunol. 1997, 80, 158-164.